| Filed On | Filing |
|---|---|
| 05 Aug 2026 |
Form 3: Getz Heather C, Director
Holds 5,000 shares of Common Stock |
| 11 Jun 2026 |
Form 3: Capper Joseph H, Director
No securities owned |
| 11 Jun 2026 |
Form 3: Neels Guido J, Director
No securities owned |
| 11 Jun 2026 |
Form 3: Thomas Paul, Director
No securities owned |
| 11 Jun 2026 |
Form 3: Nohra Guy P, Director
No securities owned |
| 11 Mar 2026 |
Form 3: Langstein Howard N., Chief Medical Officer
Holds 71,347 shares of Common Stock |
| 03 Nov 2025 |
Form 3: Plovanic William J., Director
No securities owned |
| 10 Oct 2025 |
Form 3: Rocchio Betty Jo, Director
No securities owned |
| 06 Jun 2024 |
Form 3: Blizard Jeffrey, Director
No securities owned |
| 04 Aug 2023 |
Form 3: Firestone Gregory A., Chief Business Officer
Holds 14,961 shares of Common Stock |
| 07 Jan 2022 |
Form 3: Talmo Paul, Chief Strategic Officer
Holds 30,470 shares of Common Stock |
| 07 Jan 2022 |
Form 3: Smeykal Megan, Chief Accounting Officer
Holds 7,717 shares of Common Stock |
| 29 Sep 2021 |
Form 3: Cuca Roberto, COO and CFO
No securities owned |
| 04 Jun 2021 |
Form 3: Nosenzo John, Director
No securities owned |
| 19 Feb 2021 |
Form 3: Ew Healthcare Partners Fund 2, L.p., See footnotes 1 and 2 and 3 others
Holds 599,853 shares of Common Stock, $0.001 per share |
| 22 Apr 2020 |
Form 3: Evans Douglas G, Director
No securities owned |
| 22 Apr 2020 |
Form 3: Colleran Lisa N, Director
No securities owned |
| 29 Jan 2020 |
Form 3: Murphy Peter C., Chief Commercial Officer
Holds 0 shares of No securities are beneficially owned |
| 17 Dec 2019 |
Form 3: Rtw INVESTMENTS, Lp, 10% owner and 1 other
Holds 1,151,458 shares of Common Stock |
| 07 Nov 2019 |
Form 3: Quaker BioVentures Ii Lp, 10% owner and 1 other
Holds 29,288 shares of Common Stock |
Loading...